High frequency of iron bone deposits in a Mexican population with renal osteodystrophy

Nephrology Dialysis Transplantation

Volumn 13, Issue SUPPL. 3, 1998, Pages 46-50

  Forero, Francisco Velásquez ^a,c   Altamirano, Erandira ^b   Ramos, Pedro Trinidad ^a  

^a Hospital Angeles Mocel   (Mexico)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Aluminium bone deposits; Bone iron overload; Iron bone deposits; Renal osteodystrophy

Indexed keywords

ALKALINE PHOSPHATASE; ALUMINUM; AMYLOID; CALCITONIN; CALCIUM ION; IRON; PARATHYROID HORMONE; PHOSPHORUS; TETRACYCLINE;

ADULT; BONE; BONE BIOPSY; BONE MINERALIZATION; CONFERENCE PAPER; FEMALE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; IRON STORAGE; MAJOR CLINICAL STUDY; MALE; MEXICO; MORPHOMETRICS; OSTEITIS FIBROSA; OSTEOMALACIA; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; STAINING;

ADULT; AGED; ALUMINUM; BONE AND BONES; FEMALE; HUMANS; IRON; MALE; MIDDLE AGED; RENAL OSTEODYSTROPHY;

EID: 6844255222     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.suppl_3.46     Document Type: Conference Paper

References (32)

1. Kaehny WD, Alfrey AC, Holman RE et al. Aluminum transfer during hernodialysis. Kidney Int 1977; 12: 361-365
2. Ellis HA, McCarthy JH, Herrington J. Bone aluminum in haemodialyzed patients and in rats injected with aluminum chloride: relationship to impaired bone mineralisation. J Clin Pathol 1979; 32: 832-844
3. Ott SM, Maloney NA, Coburn JW et al. The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. N Engl J Med 1982; 307: 709-713
4. Cann CE, Prussin SG, Gordan GC. Aluminum uptake by parathyroid glands. J Clin Endocrinol Metab 1979; 49: 543-545
5. Fleming LW, Steward WK, Fell GS, Halls DJ. The effect of oral aluminum therapy on plasma aluminum levels in patients with chronic renal failure in an area with low water aluminum. Clin Nephrol 1982; 17: 222-227
6. McKinney TD, Basinger M, Dawson E, Jones MM. Serum aluminum levels in dialysis dementia. Nephron 1982; 32: 53-56
7. Andress D, Felsenfeld AJ, Voigts A, Llach F. Parathyroid hormone response to hypocalcemia in hemodialysis patients with osteomalacia. Kidney Int 1983; 24: 364-370
8. Mayor GH, Keiser JA, Pao KK. Aluminum absorption and distribution: effect of parathyroid hormone. Science 1977; 197: 1187-1189
9. Cournot-Witmer G, Zingraff J, Plachot JJ et al. Aluminum localization in bone from hemodialyzed patients: relationship to matrix mineralization. Kidney Int 1981; 20: 375-385
10. Llach F, Felsenfeld AJ, Coleman MD, Keveney JR, Pederson JA, Medlock TR. The natural course of dialysis osteomalacia. Kidney Int 1986; 29 suppl 18: S-74-S-79
11. Parkinson IS, Ward MK, Feest RWP, Kerr DNS. Fracturing dialysis osteodystrophy and dialysis encephalopathy. Lancet 1979; 1: 406-409
12. Phelps KR, Vigorita VJ, Bansal M, Einhorn TA. Histochemical demonstration of iron but not aluminum in a case of dialysisassociated osteomalacia. Am J Med 1988; 84: 775-780
13. Pierides AM, Myli MP. Iron and aluminum osteomalacia in hemodialysis patients (letter). N Engl J Med 1984; 310: 323
14. Trinidad P, Velásquez Forero F, Ortiz J, La ra C, Treviño A. Utilidad de la biopsia ósea sin descalcificar en el diagnóstico de la osteodistrofia renal. Nefrol Mex 1995; 16: 19-25
15. Velásquez Forero F, Mondragón A, Herrero B, Peña JC. Adynamic bone lesion in renal transplant recipients with normal renal function. Nephrol Dial Transplant 1996; 11 (suppl 3): 58-64
16. Maloney N, Alfrey AC, Miller NL, Coburn JW, Sherrard DJ. Histologic quantitation of aluminum in iliac bone from patients with renal failure. J Lab Clin Med 1982; 199: 206-216
17. Perls M. Nachweis von Eisenoxyd in gewissen pigmenten. Virchows Arch 1967; 39-42
18. Armed Forces Institute of Pathology. Congo red (Bennhold's) method for amyloid. Laboratory Methods in Histotechnology. In: Prophed EB, Mills B, Arrington JB, Sobin LH, eds. Washington, DC: American Registry of Pathology, 1992; 168
19. Merz WA, Schenk RK. Quantitative structural analysis of human cancellous bone. Acta Anat 1970; 75: 54-66
20. Sherrard DJ, Hercz G, Pei Y et al. The spectrum of bone disease in end-stage renal failure an evolving disorder. Kidney Int 1993; 43: 436-442
21. Parfitt AM, Drezner MK, Glorieux FH et al. Bone histomorphometry standardization of nomenclature symbols and units. J Bone Miner Res 1987; 2: 595-610
22. Velásquez Forero F. La biopsia ósea metabolicaen el diagnóstico de las osteodistrofias renales. In: Llach F, Valderrábano F, eds. Insuficiencia Renal Crónica Diálisis y Trasplante Renal. Ediciones Norma Madrid, 1997; 2nd edn
23. Torres A, Lorenzo V, Hernández D et al. Bone disease in predialysis, hemodialysis, and CAPD patients evidence of a better bone response to PTH. Kidney Int 1995; 47: 1434-1442
24. Malluche HH, Monier-Faugere MC. The role of bone biopsy in the management of patients with renal osteodystrophy. Editorial review. J Am Soc Nephrol 1994; 4: 1631-1642
25. Gokal R, Millard PR, Weatherall DJ, Callender STE, Ledingham JGG, Oliver DO. Iron metabolism in haemodialysis patients. QJ Med, 1979; 48: 369-391
26. Gratwick GM, Bullough PG, Bohne WHO, Markensen AL, Peterson CM. Thalassemic osteoarthropathy. Ann Intern Med 1978; 88: 494-501
27. Cannata JB, Fernández-Soto I, Fernández-Menendez MJ et al. Role of iron metabolism in absorption and cellular uptake of aluminum. Kidney Int 1991; 39: 799-803
28. Cannata JB, Olainzola IR, Gomez-Alonso C, Menéndez-Fraga P, Alonso-Suarez M, Díaz-Lopez JB. Serum aluminum transport and aluminum uptake in chronic renal failure: role of iron and aluminum metabolism. Nephron 1993; 65: 141-146
29. Ittel TH, Kinzel S, Ortmanns A, Sieberth HG. Effect of iron status on the intestinal absorption of aluminum: a reappraisal. Kidney Int 1996; 50: 1879-1888
30. Sherrard DJ, Baylink D, Wergedal J. Bone disease in uremia. ASAIO Trans 1972; 28: 412-415
31. Ott SM, Maloney NA, Coburn JW, Alfrey AC, Sherrard DJ. The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. N Engl J Med 1982; 307: 709-714
32. Smith AJ, Faugere MC, Abreo K, Fanti P, Julian B, Malluche HH. Aluminum related bone disease in mild and advanced renal failure. Evidence for high prevalence and morbidity, and studies on etiology and diagnosis. Am J Nephrol 1986; 6: 275-283